MEDINCELL

Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Aug 2026)

What this means for you

Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Jun 2030: the §8 & §9 renewal).

Record

Serial number
88404359
Registration number
6077767
Mark type
Word mark
Filed
26 Apr 2019
Published for opposition
31 Mar 2020
Registered
16 Jun 2020
Next maintenance filing
§8 & §9 renewal, due by 16 Jun 2030 (grace period to 16 Dec 2030)
Attorney of record
Stephen P. McNamara

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; [ pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; ] veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; [ veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; ] pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders [ ; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders ]

Owner

Prosecution history

  • 31 Aug 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 31 Aug 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 31 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 23 Jun 2026 — TEAS SECTION 8 & 15 RECEIVED
  • 03 Jun 2026 — TEAS SECTION 8 & 15 RECEIVED
  • 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
  • 31 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 31 Mar 2020 — PUBLISHED FOR OPPOSITION
  • 11 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 27 Feb 2020 — ELECTRONIC RECORD REVIEW COMPLETE
  • 07 Feb 2020 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 31 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 31 Jan 2020 — EXAMINER'S AMENDMENT ENTERED
  • 31 Jan 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

View this trademark record on Rightsy